Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Atomoxetine Accord 10/18/25/40/60/80/100 mg - Hard Capsules, PA2315/019/001-007, Recall, All in-date batches
Notice type:
Recall
Date:
09/07/2024
We wish to advise you that all in-date batches of the above products are being recalled with immediate effect.
This recall is to pharmacy level.
The reason for the recall is out of specification assay results.
Wholesalers can download a copy of the
wholesaler recall letter
.
Pharmacists can download a copy of the
pharmacy recall letter
.
Product name or type:
Atomoxetine Accord Hard Capsules
Authorisation Number:
PA2315/019/001, PA2315/019/002, PA2315/019/003, PA2315/019/004, PA2315/019/005, PA2315/019/006, PA2315/019/007
Serial Or Batch Number And Expiry Date:
All in-date batches
Authorisation Holder:
Accord Healthcare Ireland Ltd
Recall Classification:
Pharmacy level recall
Target Audience:
Pharmacists and Wholesalers
Actions To Be Taken:
Information for pharmacists:
Pharmacists are requested to carry out the following actions:
1. Immediately identify and quarantine any units of these products which you have in your pharmacy. For hospital pharmacists, this includes stock on wards, in clinics and at any other relevant locations within your hospital.
2. Return quarantined units to your supplier, indicating that they are being returned as a result of this recall action.
3. If you have supplied units of these products to any other pharmacy, clinic or other such establishment, please forward a copy of the recall letter to them, and request they quarantine and return any unused units to you.
Information for patients:
If you have any queries, please contact your prescriber or pharmacist.
Adverse reactions should be reported to Accord (medinfo@accord-healthcare.com) and to the HPRA (medsafety@hpra.ie).
« Back
Date Printed: 17/09/2024